ANAVEX LIFE SCIENCES CORP. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Anavex Life Sciences Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Anavex Life Sciences Corp. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$12.2M, a 8.28% decline year-over-year.
  • Anavex Life Sciences Corp. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$41.5M, a 19.6% increase year-over-year.
  • Anavex Life Sciences Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$47.5M, a 0.99% increase from 2022.
  • Anavex Life Sciences Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$48M, a 26.6% decline from 2021.
  • Anavex Life Sciences Corp. annual Net Income (Loss) Attributable to Parent for 2021 was -$37.9M, a 44.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$41.5M -$12.2M -$934K -8.28% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$40.6M -$10.5M +$2.56M +19.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$43.2M -$8.62M +$4.35M +33.5% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-07
Q3 2023 -$47.5M -$10.1M +$4.14M +29% Jul 1, 2023 Sep 30, 2023 10-K 2023-11-27
Q2 2023 -$51.6M -$11.3M +$1.09M +8.79% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$52.7M -$13.1M -$2.67M -25.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$50.1M -$13M -$2.09M -19.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-07
Q3 2022 -$48M -$14.3M -$2.57M -21.9% Jul 1, 2022 Sep 30, 2022 10-K 2023-11-27
Q2 2022 -$45.4M -$12.4M -$2.19M -21.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$43.2M -$10.4M -$2.28M -28% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$40.9M -$10.9M -$3.03M -38.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 -$37.9M -$11.7M -$5.75M -96.4% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-27
Q2 2021 -$32.2M -$10.2M -$3.69M -56.9% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 -$28.5M -$8.16M -$919K -12.7% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-13
Q4 2020 -$27.5M -$7.86M -$1.26M -19.2% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 -$26.3M -$5.97M -$359K -6.4% Jul 1, 2020 Sep 30, 2020 10-K 2022-11-28
Q2 2020 -$25.9M -$6.49M +$35.3K +0.54% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$26M -$7.24M +$10.2K +0.14% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$26M -$6.59M +$328K +4.74% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 -$26.3M -$5.61M -$14K -0.25% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-28
Q2 2019 -$26.3M -$6.52M -$3.67M -129% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$22.6M -$7.25M -$2.49M -52.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$20.1M -$6.92M -$2.86M -70.5% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 -$17.3M -$5.59M -$438K -8.49% Jul 1, 2018 Sep 30, 2018 10-K 2019-12-16
Q2 2018 -$16.8M -$2.85M +$761K +21.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$17.6M -$4.75M -$3.2M -207% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$14.4M -$4.06M -$913K -29% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 -$13.5M -$5.15M +$1.36M +20.8% Jul 1, 2017 Sep 30, 2017 10-K/A 2019-01-25
Q2 2017 -$14.8M -$3.61M -$1.37M -61.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$13.4M -$1.55M +$482K +23.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$13.9M -$3.15M +$808K +20.4% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q3 2016 -$14.7M -$6.51M -$1.15M -21.6% Jul 1, 2016 Sep 30, 2016 10-K/A 2019-01-25
Q2 2016 -$13.6M -$2.24M +$2M +47.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$15.6M -$2.03M -$306K -17.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$15.3M -$3.95M -$3.17M -403% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-07
Q3 2015 -$12.1M -$5.36M +$2.94M +35.5% Jul 1, 2015 Sep 30, 2015 10-K 2017-12-11
Q2 2015 -$15.1M -$4.24M -$3.23M -320% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$11.8M -$1.72M -$706K -69.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$11.1M -$787K -$1.15M -319% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-08
Q3 2014 -$9.97M -$8.3M -$5.31M -178% Jul 1, 2014 Sep 30, 2014 10-K 2016-12-14
Q2 2014 -$4.66M -$1.01M -$857K -564% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$3.8M -$1.02M -$913K -860% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$2.89M $359K +$812K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 -$3.7M -$2.99M -$2.31M -343% Jul 1, 2013 Sep 30, 2013 10-K 2014-12-29
Q2 2013 -$1.39M -$152K +$4.39M +96.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$5.78M -$106K +$804K +88.3% Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-05-30
Q4 2012 -$6.58M -$454K +$1.72M +79.1% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$8.3M -$674K +$1.19M +63.9% Jul 1, 2012 Sep 30, 2012 10-Q/A 2014-05-30
Q2 2012 -$9.5M -$4.54M -$2.96M -188% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$6.53M -$910K +$1.06M +53.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-17
Q4 2011 -$7.6M -$2.17M -$288K -15.3% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q3 2011 -$7.31M -$1.87M Jul 1, 2011 Sep 30, 2011 10-Q/A 2014-05-30
Q2 2011 -$1.58M +$387K +19.7% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-17
Q1 2011 -$1.97M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 -$1.89M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q2 2010 -$1.97M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.